Daily Scientific Programme Thursday 13 June, 2019 Thursday 13 June, 2019

DAILY SCIENTIFIC PROGRAMME THURSDAY 13 JUNE, 2019 THURSDAY 13 JUNE, 2019

AMBER 1 07:00-08:00 AMBER 3 07:00-08:00

DONNE DERMATOLOGHE ITALIANE: GRUPPO SIDeMaST RICERCA SPERIMENTALE E IS Dermatology and women red face IS BIOINGEGNERIA IN DERMATOLOGIA: Research CO-CHAIRS: Corinna Rigoni (ITALY), snippets in Immune-Mediated and Oncological Norma Cameli (ITALY) diseases CO-CHAIRS: Andrea Chiricozzi (ITALY), 07:00 The Skin aging exposome Francesca Prignano (ITALY) May El Samahy (EGYPT) 07:00 Clinical relevance of the oxidoreductive pathway 07:10 Periorbital rejuvenation with EBD in chronic dermatological diseases Eman El Morsy (EGYPT) Leonardo Pescitelli (ITALY) 07:20 Radiotherapy related dermatoses 07:08 Discussion Nayera Moftah (EGYPT) 07:10 Clinico-pathological characterization of patients 07:30 Borderline lepromatous leprosy: Uncommon with localized scleroderma and response to UVA-1 presentation phototherapy: in vitro and in vivo skin models Elwan Nagwa (EGYPT) Linda Tognetti (ITALY) 07:35 The lady of the rings 07:18 Discussion Claudia Menicanti (ITALY) 07:20 Features of gut microbiota in vitiligo patients 07:40 Burning red face Roberta Colucci (ITALY) Valentina Benzecry (ITALY) 07:28 Discussion 07:45 Genodermatoses of the face Michela Brena (ITALY) 07:30 Genetic susceptibility in pediatric melanoma Cristina Pellegrini (ITALY) 07:48 Genodermatoses of the face Susanna Bernardon (ITALY) 07:38 Discussion

07:50 Red face in cancer patients 07:40 Phenotypical characterization of immune cells Sara Cacciapuoti (ITALY) associated with histological regression in cutaneous melanoma 07:55 The face of inﬂammatory diseases Simone Ribero (ITALY) Maddalena Napolitano (ITALY) 07:48 Discussion

AMBER 2 07:00-08:00 07:50 Molecular characterization of in-transit melanoma metastases and circulating melanoma cells recognizes an expression panel GRUPPO SIDeMaST DERMATOLOGIA ESTETICA: potentially related to disease progression IS Threads in aesthetic dermatology Cristina Rapanotti (ITALY) CO-CHAIRS: Lucia Brambilla (ITALY), Marina Romagnoli (ITALY) 07:58 Discussion

07:00 Biostimulation with threads: how can we armonize facial features with threads, stem cell AMBER 4 07:00-08:00 and stabilised hybrid co-operative complexes of H-HA and L-HA GRUPPO SIDeMaST PATOLOGIA DELLE MUCOSE: Marina Romagnoli (ITALY), Rosalia Russo (ITALY) IS Diagnostic of pigmentary mucosal lesions 07:15 Threads for the treatment of acne scars: a new CO-CHAIRS: Marco Ardigò (ITALY), approach Elisa Cinotti (ITALY) Gabriella Fabbrocini (ITALY) 07:00 Oral lesions 07:30 The right thread for the periocular area Vincenzo De Giorgi (ITALY) Marina Vastarella (ITALY) 07:15 Genital lesions 07:45 Side effects and how to manage them Sabina Vaccari (ITALY) Anna Masarà (ITALY) THURSDAY 13 JUNE, 2019

07:30 Conjunctival lesions 07:40 The Hospital of Santa Maria of the Incurables in Elisa Cinotti (ITALY) Naples, Italy: Its Role in the History of Dermatology 07:45 Confocal microscopy of oral and genital Patrizia Forgione (ITALY) pigmented lesions Marco Ardigò (ITALY) AMBER 1 08:00-10:45 AMBER 5+6 07:00-08:00 Pemphigoid Diseases SY CHAIR: Luca Borradori (SWITZERLAND) AIDA: Reputation and digital dermatological CO-CHAIRS: David Woodley (UNITED STATES), IS professional approach Wataru Nishie (JAPAN) CO-CHAIRS: Saturnino Gasparini (ITALY), Domenico Piccolo (ITALY) 08:00 Epidemiology and associations Li Li (CHINA) 07:00 Social Networking Sites: tools for the dermatologist’s communication 08:25 Clinical spectrum and presentations of the Federica Osti (ITALY) pemphigoid group of diseases Janet Fairley (UNITED STATES) 07:20 Dermatological internet sites: a source of public health 08:50 Pathophysiology Giovanni Menchini (ITALY) Wataru Nishie (JAPAN)

07:40 The inﬂuence of digital media on the 09:15 Diagnostic algorithm for the pemphigoid group dermatologist’s reputation of diseases: practical approach Alessandro Martella (ITALY) Detlef Zillikens (GERMANY)

09:40 Practical management of bullous pemphigoid AMBER 7+8 07:00-08:00 Luca Borradori (SWITZERLAND) 10:05 Bullous pemphigoid: new therapies on the horizon ADOI: Classification of Skin Tumors: Frédérick Caux (FRANCE) IS What’s new? 10:30 Discussion CO-CHAIRS: Cesare Massone (ITALY), Pier Alessandro Fanti (ITALY) 07:00 Updated classification of cutaneous lymphomas AMBER 2 08:00-10:45 Emilio Berti (ITALY) Update on Dermatopathology 07:25 Updated classification of melanocytic tumors SY CHAIR: Eduardo Calonje (UNITED KINGDOM) Lorenzo Cerroni (AUSTRIA) CO-CHAIRS: Philip Leboit (UNITED STATES), 07:50 Discussion Yu-Hung Wu (CHINESE TAIPEI)

08:00 Genodermatoses BROWN 1 07:00-08:00 Dieter Metze (GERMANY) 08:23 Clinicopathological correlation in GRUPPO SIDeMaST STORIA DELLA dermatopathology IS DERMATOLOGIA E VENEREOLOGIA: History of Eduardo Calonje (UNITED KINGDOM) Dermatology 08:46 Update in cutaneous lymphoma CO-CHAIRS: Cataldo Patruno (ITALY), Reuven Bergman (ISRAEL) Valeria Gaspari (ITALY) 09:09 Patterns of drug eruption 07:00 HIV/AIDS in the history of Dermatology and Yu-Hung Wu (CHINESE TAIPEI) Venereology Luigi Valenzano (ITALY) 09:32 Update in cutaneous mucinosis Franco Rongioletti (ITALY) 07:20 The Salernitan School of Medicine, pioneer of the modern medical and dermatologic science 09:55 Molecular insights into the nature and diagnosis Massimo Nacca (ITALY) of melanocytic neoplasms Philip Leboit (UNITED STATES) THURSDAY 13 JUNE, 2019

10:18 Benign mimics of cutaneous lymphoma 08:15 Differential diagnosis of palpable lesions: the Adriana Garcia (SPAIN) role of reﬂectance confocal microscopy and optical coherence tomography 10:41 Q&A - Final discussion F. Garbarino (ITALY)

08:30 Mohs micrographic surgery in Singapore: a AMBER 3 08:00-10:45 retrospective review W. Ho (SINGAPORE) Deep Fungal Infections 08:45 Predictive importance of plasma prolidase, SY CHAIR: Rataporn Ungpakorn (THAILAND) adenosine deaminase and dipeptidyl peptidase- CO-CHAIRS: Boni Elizabeth Elewski (UNITED 4 as markers of collagen turnover in relation to STATES), Alexandro Bonifaz (MEXICO) the skin core in scleroderma 08:00 Introduction of speakers H. Cocic (SERBIA)

08:05 Expert’s opinion on treatment of Sporotrichosis 09:00 A Randomized Controlled Trial of Anti-TNF Alexandro Bonifaz (MEXICO) Alpha Bio-similar Adalimumab versus Prednisolone in the Management of Leprosy 08:28 Q&A Patients with New Type 1 Lepra Reaction 08:31 Mycetoma D. Mitra (INDIA) Nejib Doss (TUNISIA) 09:15 Adult T-cell leukemia/lymphoma: report of four 08:54 Q&A cases L. Porfirio (BRAZIL) 08:57 Immunology and future application for deep fungal infections 09:30 Omalizumab versus Cyclosporin-A for the Charussri Leeyaphan (THAILAND) treatment of Chronic Spontaneous Urticaria: is there specific patient characteristics or 09:20 Q&A biomarkers to indicate response to treatment? 09:23 Dimorphic mycoses O. Su Kucuk (TURKEY) Lauren Kole (UNITED STATES) 09:45 Punctate palmoplantar keratoderma: 09:46 Q&A characterization of three families with AAGAB mutation 09:49 Superficial fungi causing deep mycoses R. Pimenta (PORTUGAL) Roderick Hay (UNITED KINGDOM) 10:00 Prurigo pigmentosa: a clinicopathologic study 10:12 Q&A of ten Chinese cases 10:15 Highlights on histopathological diagnosis of LQ W. Wang (CHINA) deep fungal infections 10:15 The value of trichoscopy in predicting the Dirk Elston (UNITED STATES) treatment outcome in patients with patchy 10:38 Q&A alopecia areata – preliminary results. M. Sikora (POLAND) 10:41 Concluding remarks 10:30 A Patient Survey of photodynamic therapy: experience from two regional services AMBER 4 08:00-10:45 B. Ho (UNITED KINGDOM)

FELLOW FORUM 3 FF CO-CHAIRS: Chun-Wei Lu (CHINA), AMBER 5+6 08:00-10:45 Anna Campanati (ITALY) New Oral Small Molecules 08:00 Factors associated with the severity of acute SY CHAIR: Lone Skov (DENMARK) ocular involvement in Stevens-Johnson CO-CHAIRS: Aleksandar Sekulic (UNITED syndrome and toxic epidermal necrolysis in sub STATES), Brett King (UNITED STATES) Saharan Africa A. S. Akakpo (TOGO) 08:00 Introduction THURSDAY 13 JUNE, 2019

08:10 New Oral Small Molecules for non-melanoma 10:15 PDT for inﬂammatory skin disorders skin cancer Cheng-Che Eric Lan (CHINESE TAIPEI) Aleksandar Sekulic (UNITED STATES) 10:35 Discussion and Closure of Session 08:30 Q&A

08:35 New Oral Small Molecules for melanoma BLUE 1 08:00-10:45 Paola Queirolo (ITALY)

08:55 Q&A Basic Cosmetic Dermatology CO CHAIR: Marina Landau (ISRAEL) 09:00 New Oral Small Molecules for lupus and related CO-CHAIRS: Joyce Lim (SINGAPORE), diseases Carlos Wambier (BRAZIL) Marzia Caproni (ITALY) 08:00 Why dermatologists should take care of 09:20 Q&A cosmetic patients? 09:25 New Oral Small Molecules for psoriasis Marina Landau (ISRAEL) Lars Iversen (DENMARK) 08:13 The art and science of cosmetic consultation 09:45 Q&A Nancy Garcia Tan (PHILIPPINES)

09:50 New Oral Small Molecules for atopic dermatitis 08:24 Basic surface anatomy relevant for injectors Thomas Bieber (GERMANY) Tatjana Pavicic (GERMANY)

10:10 Q&A 08:35 BtxA – The Dos and Don’ts Doris Hexsel (BRAZIL) 10:15 JAK inhibitors in inﬂammatory skin diseases besides atopic dermatitis and psoriasis 08:46 What dermatologist should know before Brett King (UNITED STATES) starting to treat a skin of color? Pearl Grimes (UNITED STATES) 10:35 Q&A 08:57 Dermal ﬁllers – how do I use them in my practice? 10:40 Conclusions Gary D. Monheit (UNITED STATES)

09:08 Q&A AMBER 7+8 08:00-10:45 09:18 Female intimate rejuvenation: The why, when and how Photodynamic Therapy Nicola Zerbinati (ITALY) SY CHAIR: Rolf-Markus Szeimies (GERMANY) CO-CHAIRS: Colin Morton (UNITED KINGDOM), 09:29 The dark side of dermal fillers – inflammatory Luis Antonio Torezan (BRAZIL) and vascular fillers complications: how to avoid and treat 08:00 Welcome and Introduction Joyce Lim (SINGAPORE) Rolf-Markus Szeimies (GERMANY) 09:41 Chemical peels – why dermatologists must use 08:05 PDT basics them? Luis Antonio Torezan (BRAZIL) Carlos Wambier (BRAZIL) 08:25 PDT for non-melanoma skin cancer 09:53 Energy based devices – what should be our first Colin Morton (UNITED KINGDOM) choices of equipment in treating Caucasians and 08:45 PDT for actinic keratoses why? Rolf-Markus Szeimies (GERMANY) Moshe Lapidoth (ISRAEL)

09:05 Discussion 10:05 Energy based devices – what should be our ﬁrst choices of the machines in treating Asian 09:15 Aesthetic PDT patients and why? Nellie Konnikov (UNITED STATES) Chee Leok Goh (SINGAPORE) 09:35 Antimicrobial PDT 10:20 Do we need autologous products for aging Yolanda Gilaberte (SPAIN) prevention and restoration? 09:55 PDT in transplant recipients Martina Kerscher (GERMANY) Stefano Piaserico (ITALY) 10:35 Q&A THURSDAY 13 JUNE, 2019

BLUE 2 08:00-10:45 09:40 Management of rare CTCLs including SPTCL and G/D TCL Basic Dermatological Surgery Pietro Quaglino (ITALY) CO CHAIR: Christopher Arpey (UNITED STATES) 10:00 Approach to management of cutaneous B cell CO-CHAIRS: Luiz Guilherme Castro (BRAZIL), lymphoma Andrea Paradisi (ITALY) Joan Guitart (UNITED STATES)

08:00 Preoperative Considerations 10:20 Current concepts in CD30+ lymphoproliferative Christian L. Baum (UNITED STATES) disorders 08:15 Critical anatomy pearls/Danger zones Alessandro Pileri (ITALY) Luiz Guilherme Castro (BRAZIL) 10:40 Q&A 08:35 Essentials Instruments/Suture Material Ally-Khan Somani (UNITED STATES) BROWN 2 08:00-10:45 08:55 Electrosurgery basics Jerry D. Brewer (UNITED STATES) Bacterial infections of the skin 09:10 Questions SY CHAIR: Francisco Bravo (PERU) CO-CHAIRS: Roshidah Baba (MALAYSIA), 09:20 Local anesthesia tips Alireza Khatami (IRAN) Myrto-Georgia Trakatelli (GREECE) 08:00 Global Burden of bacterial skin 09:40 Biopsy Pearls infections Jenda Ricar (CZECH REPUBLIC) Alireza Khatami (IRAN)

10:00 Suturing Techniques 08:20 Cutaneos tuberculosis Andrea Paradisi (ITALY) Ivonne Arellano Mendoza (MEXICO)

10:20 Cryosurgery 08:40 Buruli ulcer Paola Pasquali Toledo (SPAIN) Filippo La Rosa (ITALY)

10:35 Questions 09:00 Common bacterial infections in outpatients and inpatients Juan Carlos Diez de Medina (BOLIVIA) BROWN 1 08:00-10:45 09:20 Leprosy Cutaneous Lymphoma: Classiﬁcation and Carolina Talhari (BRAZIL) SY Management 09:40 Borreliosis CHAIR: Emilio Berti (ITALY) Almut Boer (GERMANY) CO-CHAIRS: Xavier Rueda (COLOMBIA), Youn Kim (UNITED STATES) 10:00 Bartonellosis, endemic and cosmopolitan Francisco Bravo (PERU) 08:00 Overview of updates in the WHO classiﬁcation Emilio Berti (ITALY) 10:20 Q&A

08:20 Updates in molecular pathogenesis and biomarkers in MF/SS Maarten Vermeer (NETHERLANDS) BROWN 3 08:00-10:45

08:40 Management of early stage mycosis fungoides Neutrophilic Dermatoses (MF) SY CHAIR: Mark Davis (UNITED STATES) Julia Scarisbrick (UNITED KINGDOM) CO-CHAIRS: Alessandro Navarini 09:00 Management of Sézary syndrome (SS) (SWITZERLAND), Angelo Valerio Marzano Youn Kim (UNITED STATES) (ITALY)

09:20 Experience in NK/T-cell lymphomas 08:00 Neutrophilic diseases: an overview Xavier Rueda (COLOMBIA) Mark Davis (UNITED STATES) THURSDAY 13 JUNE, 2019

08:20 Pyoderma gangrenosum SPACE 1 08:00-10:45 Stanislav Tolkachjov (UNITED STATES)

08:40 Sweet’s Syndrome Atopic Eczema: Management Alex Ortega Loayza (UNITED STATES) SY CHAIR: Carsten Flohr (UNITED KINGDOM) CO-CHAIRS: Alan Irvine (IRELAND), 09:00 Syndromic pyoderma gangrenosum and other Giampiero Girolomoni (ITALY) rarer neutrophilic diseases Angelo Valerio Marzano (ITALY) 08:00 When is systemic therapy warranted? Phyllis Spuls (NETHERLANDS) 09:20 Neutrophilic diseases in childhood Antonio Torrelo (SPAIN) 08:25 The place for conventional systemic therapy in the biologic era 09:40 Skin and autoinﬂammation Jorien van der Schaft (NETHERLANDS) Alessandro Navarini (SWITZERLAND) 08:50 Novel systemic therapies 10:00 Treatment of neutrophilic diseases Kenji Kabashima (JAPAN) Philip Hampton (UNITED KINGDOM) 09:15 The role of skin infection in AD: when to treat? 10:20 Discussion Claudia Traidl-Hoffmann (GERMANY)

09:40 Manipulation of the host microbiome RED 1+2 08:00-10:45 Tilo Biedermann (GERMANY) 10:05 Treatment of itch Dermoscopy of Pigmented Lesions Gil Yosipovic (UNITED STATES) SY CHAIR: Iris Zalaudek (AUSTRIA) CO-CHAIRS: Allan Halpern (UNITED STATES), 10:30 Discussion Wilhelm Stolz (GERMANY) 08:00 Advances in skin imaging SPACE 2 08:00-10:45 Allan Halpern (UNITED STATES)

08:15 Genes and patterns of melanoma Management of Androgenetic Alopecia Susana Puig (SPAIN) SY CHAIR: George Cotsarelis (UNITED STATES) CO-CHAIRS: Won-Soo Lee (KOREA, REPUBLIC 08:30 Genes and patterns of nevi OF), Rodney Sinclair (AUSTRALIA) Peter Soyer (AUSTRALIA) 08:00 Systemic Causes of Hair Loss 08:45 Patients with multiple nevi Lynn Drake (UNITED STATES) Iris Zalaudek (AUSTRIA) 08:20 Updates on the management of male AGA 09:00 Implementing dermoscopy in everyday practice Won-Soo Lee (KOREA, REPUBLIC OF) Petr Arenberger (CZECH REPUBLIC) 08:40 Post ﬁnasteride syndrome 09:15 Special anatomic body sites - why and how to Ken Washenik (UNITED STATES) manage Wilhelm Stolz (GERMANY) 09:00 Cicatricial Alopecias Wilma Bergfeld (UNITED STATES) 09:30 Dermoscopy in the treatment decision Aimilios Lallas (GREECE) 09:20 Break

09:45 The many faces of seborrheic keratoses 09:35 Update on Female Pattern Hair Loss Caterina Longo (ITALY) Rodney Sinclair (AUSTRALIA)

10:00 Diagnosis and management of congenital 09:55 Prostaglandins and hair loss melanocytic nevi George Cotsarelis (UNITED STATES) Ashfaq Marghoob (UNITED STATES) 10:15 Pathomechanism of permanent hair loss after 10:15 Dermoscopy of pigmented lesions chemotherapy - priming mobilization and Elisa Cinotti (ITALY) depletion of hair follicle stem cells Ohsang Kwon (KOREA, REPUBLIC OF) 10:30 Q&A 10:35 Q&A THURSDAY 13 JUNE, 2019

SPACE 3 08:00-10:45 09:20 Psoriasis Comorbidities - What do the registries tell us Newly described skin disorders Matthias Augustin (GERMANY) SY CHAIR: Bruce Thiers (UNITED STATES) 09:40 Psychological impact CO-CHAIRS: Abdul-Ghani Kibbi (LEBANON), Francesca Sampogna (ITALY) Sunil Kalia (CANADA) 10:00 Challenging Cases - Psoriasis with 08:00 Introduction Co-Morbidities Bruce Thiers (UNITED STATES) Robert Gniadecki (CANADA)

08:05 Molecular characterization of disease phenotypes 10:20 Q&A Mark C. Udey (UNITED STATES)

08:25 New pediatric diseases Antonio Torrelo (SPAIN) WHITE 1 08:00-10:45

08:45 New infectious diseases Skin imaging other than dermatoscopy Omar Lupi da Rosa Santos (BRAZIL) FC CO-CHAIRS: Agnes Heng (MALAYSIA), 09:05 New insights into bullous pemphigoid Rainer Hofmann-Wellenhof (AUSTRIA) Hideyuki Ujiie (JAPAN) 08:00 Introduction

09:25 Neutrophil-mediated diseases 08:05 Novel technologies to investigate the Dany Nassar (LEBANON) distribution of facial melanin pigmentation 09:45 Syndromic hidradenitis suppurativa W. Arkesteijn (NETHERLANDS) John Ingram (UNITED KINGDOM) 08:15 A super-resolution method for skin imaging 10:05 Inherited cancer syndromes with skin A. Avanaki (UNITED STATES) manifestations 08:25 Resolution of chronic plaque psoriasis with Alexandros Stratigos (GREECE) Secukinumab – a 3-dimensional photographic 10:25 Skin diseases ﬁrst reported by Chinese representation dermatologists R. Sinclair (AUSTRALIA) Jianzhong Zhang (CHINA) 08:35 A Deep Learning approach to automatically classify skin inﬂammation of in vivo confocal images SPACE 4 08:00-10:45 D. Boudier (FRANCE)

Investigation and Management of Psoriasis 08:45 Artificial Intelligence For The Objective SY Associated Comorbidity Assessment Of Acne Grading In Clinical Trials CHAIR: Colin Thiam Seng Theng (SINGAPORE) A. Cherubini (ITALY) CO-CHAIRS: Paolo Gisondi (ITALY), 08:55 Reflectance confocal microscopy: a new Christopher Baker (AUSTRALIA) algorithm to differentiate challenging 08:00 How to build an effective Patient-Physician melanocytic skin lesions relationship in the setting of psoriasis R. de Paula Ramos Castro (BRAZIL) Christine Bundy (UNITED KINGDOM) 09:05 Differentiation of inflammatory 08:20 The role of dermatologist in the management of papulosquamous skin diseases based on skin patients with psoriatic arthritis biophysical and ultrasonographic properties: Paolo Gisondi (ITALY) A decision tree model A. Firooz (IRAN) 08:40 Managing psoriasis in obese patients Peter Foley (AUSTRALIA) 09:15 Assessment of the Lip Barrier: Microspectroscopic Confocal Raman 09:00 Do biologics in patients with psoriasis improve Spectroscopy and Macroscopic Biophysical cardiovascular risk? Measurements Kim Alexander Papp (CANADA) H. Gunt (UNITED STATES) THURSDAY 13 JUNE, 2019

09:25 Development of Artificial Intelligence based 08:35 The role of Hydroxychloroquine Sulfate mobile application for ten common (Plaquenil) therapy in eosive oral Lichen Planus dermatological diseases Z. Khamaysi (ISRAEL) S. Gupta (INDIA) 08:45 Comparative evaluation of efficacy of 09:35 Usefulness of videodermoscopy in the diagnosis intralesional mycobacterium W vaccine versus of demodicosis intralesional measles mumps rubella vaccine O. Karadag Kose (TURKEY) versus autoimplantation therapy in cutaneous warts 09:45 Ultrasound imaging in skin lesions – a non S. Kumar (INDIA) invasive tool R. Konathan (INDIA) 08:55 The Effect of Omalizumab in Mastocytosis Patients. Prospective double-blind, placebo 09:55 Xanthogranulomas and Xanthomas: 23 lesions controlled multicentre study (XOLMA-Study) evaluated by reflectance confocal microscopy J. Maul (SWITZERLAND) A. Lamberti (ITALY) 09:05 Electrochemotherapy in elderly, nonsurgical, 10:05 Quantification of Change in 3D Face Shape With skin malignancies of the Head and Neck Ageing Across Different Ethnic Groups patients: clinical outcome and quality of life P. Matts (UNITED KINGDOM) management 10:15 The Impact of Reflectance Confocal Microscopy A. Bonadies (ITALY) in Xeroderma Pigmentosum 09:15 Cilostazole as a preferred drug in the treatment L. Rocha (BRAZIL) of chilblains 10:25 Utility of High Frequency Ultrasonography M. Shishak (INDIA) (HFUS) in the diagnosis of Nail Diseases 09:25 Effects of hydroxyapatite nanoparticles on S. Tambe (INDIA) proliferation and apoptosis of human squamous 10:35 Cutaneous acute graft-versus-host disease cell carcinoma cell line A431 in vitro and in vivo assessment by confocal video microscopy J. Tang (CHINA) E. Tkaczyk (UNITED STATES) 09:35 Oral itraconazole can down-regulate serum PDGF-A of children with infantile WHITE 2 08:00-10:05 hemangioma Y. Ran (CHINA)

Medical therapies 09:45 Efficacy and Safety of Sirolimus in the Treatment FC CO-CHAIRS: Mauro Salvatore Alessandro Alaibac of Blue Rubber Bled Nevus Syndrome in (ITALY), Kwang Hoon Lee (KOREA, REPUBLIC OF) Pediatric Patients B. Zhang (CHINA) 08:00 Introduction 09:55 Topical proline therapy in Prolidase deﬁciency 08:05 DC-HIL is a novel immune checkpoint and a D. P. Thekkinadeth (INDIA) promising target for treating melanoma and other cancers P. Cruz (UNITED STATES) WHITE 2 10:05-10:45 08:15 CRISPR/Cas9-homologous recombination mediated correction of Epidermolysis Bullosa Epidemiology Simplex mutations FC CO-CHAIRS: Mauro Salvatore Alessandro Alaibac M. Bchetnia (CANADA) (ITALY), Kwang Hoon Lee (KOREA, REPUBLIC OF) 08:25 Extracorporal photopheresis with 5 aminolevulinic acid in patients with chronic 10:05 Chemoprophylaxis and immunoprophylaxis in graft-versus-host disease – preliminary results preventing leprosy in patient contacts from a pilot study R. Baskota (NEPAL) E. Christensen (NORWAY) THURSDAY 13 JUNE, 2019

10:15 Prevalence of Use Of Skin Lightening Agents 08:00 The ichthyoses: genes and phenotypes Among Participants In A Community Outreach In Judith Fischer (GERMANY) South-Eastern Nigeria 08:20 Q&A C. Onyekonwu (NIGERIA) 08:25 Syndromic ichthyoses: genes and phenotypes 10:25 MC1R variants in childhood and adolescent Alain Hovnanian (FRANCE) melanoma: a pooled-analysis from a large worldwide multicenter cohort of patients 08:45 Q&A C. Pellegrini (ITALY) 08:50 Disease pathways and therapeutic approaches in 10:35 Epidemiology of Dry Skin in the General the ichthyoses Population Amy Paller (UNITED STATES) M. Augustin (GERMANY) 09:10 Q&A

09:15 The keratodermas: genes and phenotypes YELLOW 1 08:00-10:45 Yang Yong (CHINA) 09:35 Q&A Sex hormones and the skin SY CHAIR: Christos C. Zouboulis (GERMANY) 09:40 Syndromic keratodermas: genes and phenotypes CO-CHAIRS: Mahira El Sayed (EGYPT), Keith Choate (UNITED STATES) Hironobu Sasano (JAPAN) 10:00 Q&A 08:00 The role of sex hormones in wound healing 10:05 Disease pathways and therapeutic strategies in Matthew J. Hardman (UNITED KINGDOM) the keratodermas 08:19 Sexual hormones and pigmentation David Kelsell (UNITED KINGDOM) Mauro Picardo (ITALY) 10:25 Q&A 08:38 Sexual hormones and alopecia: the follicular 10:30 The epidermal barrier: what have we learnt, interplay where do we go Catherine M. Stefanato (UNITED KINGDOM) Daniel Hohl (SWITZERLAND) 08:57 The role of metabolic syndrome in female 10:40 Q&A pattern hair loss Mahira El Sayed (EGYPT) 09:16 Role of androgens in sebaceous gland YELLOW 3 08:00-10:45 physiology and pathology Hironobu Sasano (JAPAN) The Future of Antimicrobials SY CHAIR: Xinghua Gao (CHINA) 09:35 Hyperandrogenism and acnes CO-CHAIRS: Anna Di Nardo (UNITED STATES), Gabriella Fabbrocini (ITALY) Kenshi Yamasaki (JAPAN) 09:54 Menopause, HRT and skin disorders 08:00 New antibiotics for acne Christos C. Zouboulis (GERMANY) Seemal Desai (UNITED STATES) 10:13 Endocrine-disrupting chemicals and skin 08:25 Antimicrobial peptides at the epithelial interface manifestations Yuping Lai (CHINA) Qiang Ju (CHINA) 08:45 Antimicrobial peptides and their role in dermal 10:32 Q&A cells Anna Di Nardo (UNITED STATES) YELLOW 2 08:00-10:45 09:05 Antimicrobial peptides in autoimmune diseases Michel Gilliet (SWITZERLAND) Ichthyoses and Keratodermas SY CHAIR: David Kelsell (UNITED KINGDOM) 09:25 Antimicrobial peptides in palmoplantar CO-CHAIRS: Daniel Hohl (SWITZERLAND), pustolosis Keith Choate (UNITED STATES) Masamoto Murakami (JAPAN)

09:45 Antimicrobial peptides in rosacea Kenshi Yamasaki (JAPAN) THURSDAY 13 JUNE, 2019

10:05 Clioquinol, basic and clinical reseach as an AMBER 2 14:30-16:30 alternative antimicrobial agent Yuping Ran (CHINA) Pitfalls of diagnosis in skin of colour 10:25 Modulation of Staphylococcus epidermidis WS CHAIR: Seemal Desai (UNITED STATES) bioactivity by Malassezia furfur CO-CHAIRS: Ophelia Dadzie (UNITED KINGDOM), Xinghua Gao (CHINA) Rashmi Sarkar (INDIA) 14:30 Introduction & Welcome by the Chairs GOLD 11:00-12:30 14:41 Ancillary diagnostic tools Ophelia Dadzie (UNITED KINGDOM)

CO-CHAIRS: Martine Bagot (FRANCE), 14:52 Photo protection and Clinical Potpourri PL Matilda Bylaite (LITHUANIA), Ivonne Arellano Mendoza (MEXICO) Christopher Griffiths (UNITED KINGDOM), Abdul-Ghani Kibbi (LEBANON) 15:03 Psoriasis and its mimickers Seemal Desai (UNITED STATES) 11:00 Generational aspects of life Paul Redmond (UNITED KINGDOM) 15:14 Disorders of hypo pigmentation and depigmentation 11:30 Psoriasis in 2019 Pearl Grimes (UNITED STATES) Jonathan Barker (UNITED KINGDOM) 15:25 Melasma and Hyperpigmentation 11:50 Insights into Skin Function: Lessons Learned Rashmi Sarkar (INDIA) from Genodermatoses Leena Bruckner-Tuderman (GERMANY) 15:36 Hair and scalp disorders Amy McMichael (UNITED STATES) 12:10 Can a Dermatologist Practice Without Dermoscopy? 15:47 Pitfalls in Skin of Color Aesthetics Giuseppe Argenziano (ITALY) Sahar Ghannam (CANADA) 15:58 Semiology & grading scales - “one-size does not ﬁt all” AMBER 1 14:30-16:30 Jianzhong Zhang (CHINA)

Mycobacterial infections in the Biologic Era 16:09 Chemical Peels in Skin of Color WS CHAIR: Josè Fernando Barba Gomez (MEXICO) Carlos Wambier (BRAZIL) CO-CHAIRS: Domenico Bonamonte (ITALY), 16:20 Q&A Farhad Handjani (IRAN)

14:30 Cutaneous tuberculosis: an update Francisco Bravo (PERU) AMBER 3 14:30-16:30

14:45 Childhood cutaneous tuberculosis HPV: Warts, Vaccines and Cancer Farhad Handjani (IRAN) WS CHAIR: Mihael Skerlev (CROATIA) 15:00 Diagnosis of cutaneous tuberculosis CO-CHAIRS: Jinhua Xu (CHINA), Eduardo Poletti (MEXICO) Antonio Cristaudo (ITALY)

15:15 Cutaneous tuberculosis and HIV infection 14:30 The global burden of HPV infections and related Archana Singal (INDIA) diseases Electra Nicolaidou (GREECE) 15:30 Latent tuberculosis infection in patient with psoriasis taking biologic therapies 14:45 HPV infection in China: prevalence, research and Omid Zargari (IRAN) perspective Hao Cheng (CHINA) 15:45 Skin infections by nontuberculous mycobacteria Domenico Bonamonte (ITALY) 15:00 Anal and oral HPV infection in the male at risk Antonio Cristaudo (ITALY) 16:00 Atypical Mycobacterial Infections in Mexico Roberto Arenas (MEXICO) 15:15 An update on HPV - associated penile and anal dysplastic lesions 16:15 Discussion Arne Wikström (SWEDEN) THURSDAY 13 JUNE, 2019

15:30 The frustrations and complications of the HPV 15:30 Less explored and experimental treatments for treatments keloid Suzana Ljubojević Hadžavdić (CROATIA) Somesh Gupta (INDIA)

15:45 What is really “old” and really “new” in the HPV 15:42 Combining treatments in the treatment of keloids World? David Ozog (UNITED STATES) Marco Cusini (ITALY) 15:54 Panel discussion with cases 16:00 Nine shades of the HPV prophylaxis Greg Goodman (AUSTRALIA) Mihael Skerlev (CROATIA) 16:18 Q&A 16:15 Discussion

AMBER 7+8 14:30-16:30 AMBER 4 14:30-16:30 Advances in the Management of Melanoma Epidermolysis Bullosa WS CHAIR: Alexander Enk (GERMANY) WS CHAIR: Katsuto Tamai (JAPAN) CO-CHAIRS: Susan Swetter (UNITED STATES), CO-CHAIRS: Peter Marinkovich (UNITED STATES), Hiroshi Koga (JAPAN) Giovanna Zambruno (ITALY) 14:30 New Molecular Techniques for Cutaneous 14:30 Overview of EB diagnosis Melanoma Diagnosis Jouni Uitto (UNITED STATES) Pedram Gerami (UNITED STATES)

14:54 Novel EB subtytpes 14:45 Discussion Giovanna Zambruno (ITALY) 14:50 Artiﬁcial Intelligence for Cutaneous Melanoma 15:18 Overview of EB therapy Detection Leena Bruckner-Tuderman (GERMANY) Susan Swetter (UNITED STATES)

15:42 Regenerative therapy of EB 15:05 Discussion Katsuto Tamai (JAPAN) 15:10 Novel Combination Therapies in Advanced 16:06 Molecular therapy of EB Melanoma Peter Marinkovich (UNITED STATES) Dirk Schadendorf (GERMANY)

15:25 Discussion AMBER 5+6 14:30-16:30 15:30 New Aspects of Adjuvant Melanoma Treatment Claus Garbe (GERMANY) Optimising the management of Keloids 15:45 Discussion WS CHAIR: Greg Goodman (AUSTRALIA) CO-CHAIRS: Ardeshir Bayat (UNITED KINGDOM), 15:50 Advanced Imaging Technology in Early Somesh Gupta (INDIA) Melanoma Detection Peter Soyer (AUSTRALIA) 14:30 Recent concepts in the Etiology and pathogenesis of keloids 16:05 Discussion Greg Goodman (AUSTRALIA) 16:10 Mutations, metastasis and the importance of 14:42 Prevention of keloids multidisciplinary management Ardeshir Bayat (UNITED KINGDOM) Victoria Mar (AUSTRALIA)

14:54 Injectable steroids and cytotoxics in the 16:25 Discussion treatment of keloids Christine Dierickx (BELGIUM) BLUE 1 14:30-16:30 15:06 Lasers and energy based devices in the treatment of keloids Advanced Cosmetic Dermatology Matteo Tretti Clementoni (ITALY) CO CHAIR: Andrè Braz (BRAZIL) 15:18 Cryotherapy for keloids CO-CHAIRS: Abdullah Al Eisa (SAUDI ARABIA), Somesh Gupta (INDIA) Sue Ellen Cox (UNITED STATES) THURSDAY 13 JUNE, 2019

14:30 Neuromodulators to the face: how to avoid and 16:00 Common complications and troubleshooting to treat the complications them Doris Hexsel (BRAZIL) Christopher Arpey (UNITED STATES)

14:42 Advanced use of Fillers (HA) to the Upper face 16:20 Questions (Forehead, glabella and temples) Ada Trinidade de Almeida (BRAZIL) BROWN 1 14:30-16:30 14:54 Advanced use of Fillers (HA) to the Mid-face (Tear trough, Malar, zygoma) Confocal Microscopy Vince Bertucci (CANADA) WS CHAIR: Pascale Guitera (AUSTRALIA) 15:06 Advanced use of Fillers (HA) to the lips and CO-CHAIRS: Caterina Longo (ITALY), Salvador perioral region Gonzalez (SPAIN) Hassan Ibrahim Hassan Galadari (UNITED ARAB 14:30 Technique and semiology/pitfall of the EMIRATES) beginner 15:18 Advanced use of Fillers (HA) to the Lower face Alon Scope (ISRAEL) (Chin, pre-jowl, jaw line, jaw angle) 14:42 Q&A Andrè Braz (BRAZIL) 14:45 Tips to integrate RCM in the practice ﬂow & 15:30 Fillers complications, how to manage? when it is worth the time: melanocytic lesions Rebecca Fitzgerald (UNITED STATES) Caterina Longo (ITALY) 15:42 Neck and Chest (biostimulators + 14:57 Q&A neuromodulators) Dee Anna Glaser (UNITED STATES) 15:00 Tips to integrate RCM in the practice ﬂow & when it is worth the time: non-melanocytic 15:54 Use of Fillers to Hands and Body lesions Sue Ellen Cox (UNITED STATES) Salvador Gonzalez (SPAIN) 16:06 Neuromodulators, 20 years experience in 15:12 Q&A middle east Abdullah Al Eisa (SAUDI ARABIA) 15:15 Amelanotic melanoma and differential Pascale Guitera (AUSTRALIA) 16:18 Q&A 15:27 Q&A

BLUE 2 14:30-16:30 15:30 Macules of the face Harald Kittler (AUSTRIA)

Basic Dermatological Surgery 15:42 Q&A CO CHAIR: Christopher Arpey (UNITED STATES) 15:45 Ex vivo confocal microscopy of the skin- CO-CHAIRS: Luiz Guilherme Castro (BRAZIL), prospective Andrea Paradisi (ITALY) Susana Puig (SPAIN) 14:30 Excision and common excisional variations 15:57 Q&A Elena Rossi (ITALY) 16:00 Vitiligo Surgery and Confocal 14:50 Exteriorization techniques Steven Tien Guan Thng (SINGAPORE) Roland Kaufmann (GERMANY) 16:12 Q&A 15:10 Intraoperative considerations Maria Cristina Messina (BRAZIL) 16:15 Difficult cases Anthony Rossi (UNITED STATES) 15:30 Questions 15:40 Postoperative management and wound management Miguel Sanchez Viera (SPAIN) THURSDAY 13 JUNE, 2019

BROWN 2 14:30-16:30 15:50 Threads and Sutures – the long and short of it Fabio Cuiabano (BRAZIL)

Classiﬁcation and Management of Panniculitis 16:05 Discussion WS CHAIR: Mark Pittelkow (UNITED STATES) CO-CHAIRS: Bernhard Zelger (AUSTRIA), 16:10 The role of injectable lipolysis on the face Marcello Menta Simonsen Nico (BRAZIL) Shannon Humphrey (CANADA)

14:30 Panniculitis Overview - Classiﬁcation and 16:25 Discussion Pathology Bernhard Zelger (AUSTRIA) SPACE 1 14:30-16:30 14:50 Lymphoproliferative Panniculitides Joan Guitart (UNITED STATES) Running a Patch Test Clinic 15:10 Panniculitis of Rheumatic Syndromes WS CHAIR: Jason Williams (UNITED KINGDOM) Franco Rongioletti (ITALY) CO-CHAIRS: David Cohen (UNITED STATES), Marlene Isaksson (SWEDEN) 15:30 Lipodermatosclerosis and other sclerosing Panniculitides 14:30 Patch Testing Basics Tania Philips (UNITED STATES) David Cohen (UNITED STATES)

15:45 Erythema Induratum 14:50 Patch Testing Readings Marcello Menta Simonsen Nico (BRAZIL) Jason Williams (UNITED KINGDOM)

16:00 Calciphylaxis-A Unique Thrombosing 15:10 Importance of Data collection and Analysis Panniculitis Francesca Larese (ITALY) Rokea El-Azhary (UNITED STATES) 15:30 Optimal clinic support for Patch testing 16:15 Alpha-1 antitrypsin and Enzymatic Marlene Isaksson (SWEDEN) Panniculitides 15:50 Special Considerations in Occupational contact Mark Pittelkow (UNITED STATES) dermatitis Adriene Lee (AUSTRALIA) BROWN 3 14:30-16:30 16:10 Patch Testing in Brazil Facial Rejuvenation: Beyond Fillers and Toxins Ida Duarte (BRAZIL) WS CHAIR: Fabio Cuiabano (BRAZIL) CO-CHAIRS: Norma Cameli (ITALY), Gary D. Monheit (UNITED STATES) SPACE 2 14:30-16:30

14:30 Chemical peels - are the “modern” twists on this Nail Dermoscopy old standard worthwhile? CO CHAIR: Bianca Maria Piraccini (ITALY) Gary D. Monheit (UNITED STATES) CO-CHAIRS: Luc Thomas (FRANCE), 14:45 Discussion Sergio Hirata (BRAZIL) 14:50 Laser resurfacing - can we get better results 14:30 Nail dermoscopy: procedure and signs without more downtime? Michela Starace (ITALY) Diletta Bonciani (ITALY) 14:46 Onychomycosis 15:05 Discussion André Lencastre (PORTUGAL) 15:10 Photorejuvenation with non ablative lasers and 14:57 Inﬂammatory diseases lights - which technologies for which patients? Je ho Mun (KOREA, REPUBLIC OF) Norma Cameli (ITALY) 15:08 Non-melanocytic nail tumors 15:25 Discussion Luc Thomas (FRANCE) 15:30 My experience with microneedling - where, when 15:19 Nail pigmentations and how to use for best Ralph Daniel (UNITED STATES) Otavio Macedo (BRAZIL) 15:30 Melanocytic nail tumors 15:45 Discussion Bianca Maria Piraccini (ITALY) THURSDAY 13 JUNE, 2019

15:41 Intraoperative dermoscopy of pigmented nail SPACE 4 15:30-16:30 Sergio Hirata (BRAZIL)

15:52 Intraoperative dermoscopy of unpigmented nail Atopic Dermatitis: Does early, aggressive conditions CN therapy change the natural history? Amelie Boespﬂug (FRANCE) CHAIR: Omar Lupi da Rosa Santos (BRAZIL) DISCUSSANT: 16:03 Test your skills! Against - Diamant Thaci (GERMANY), Bianca Maria Piraccini (ITALY) For - Lawrence Eichenﬁeld (UNITED STATES) 16:14 Test your skills! Luc Thomas (FRANCE) WHITE 1 14:30-16:30

SPACE 3 14:30-16:30 Sexually transmitted infections, tropical and FC humanitarian dermatology Flaps and Grafts CO-CHAIRS: Sergio Di Nuzzo (ITALY), WS CHAIR: Enrique Herrera Acosta (SPAIN) George Sorin Tiplica (ROMANIA) CO-CHAIRS: Richard Motley (UNITED KINGDOM), 14:30 Diagnosis and identification by PCR-RFLP of Mario Puviani (ITALY) leishmania species isolated from patients with 14:30 Planning and executing flaps, technique and cutaneous leishmaniasis in Venezuela principles behind specific flaps A. Armand Mijares (VENEZUELA) Gaston Galimberti (ARGENTINA) 14:40 Skin as a mirror of arsenic contamination of 14:43 Planning and executing grafts ground water: an observational study Jorge Alonso Suarez Perez (SPAIN) A. Das (INDIA)

14:56 Lip reconstruction 14:50 Collaboration experience between Dermatology Jean Michael Amici (FRANCE) Unit and Infectious Disease Clinic in Modena: optimization strategies for HIV, hepatitis and 15:09 Eyelid reconstruction syphilis screening tests Richard Motley (UNITED KINGDOM) F. Di Tullio (ITALY)

15:22 Forehead and scalp reconstruction 15:00 Cutaneous manifestations of the immune David Ramirez Moreno (SPAIN) reconstitution inﬂammatory syndrome (IRIS): a 15:35 Nose reconstruction case-series Mario Puviani (ITALY) M. Fernández-Sánchez (MEXICO)

15:48 Ear reconstruction 15:10 A study on clinical and sociodemographic Klaus Eisendle (ITALY) features of Trichomoniasis in symptomatic and asymptomatic female patients attending std 16:01 Danger zones reconstruction clinic using wet mount and culture as diagnostic Ramon Pigem (SPAIN) tool 16:14 Discussion and Q&A A. Manohar Prasad (INDIA) 15:20 Unusual clinical pictures of old world cutaneous leishmaniasis SPACE 4 14:30-15:30 A. Momeni (IRAN)

Psoriasis: Can biologics ever be stopped? 15:30 Childhood sexually transmitted diseases CN CHAIR: Brigitte Dréno (FRANCE) P. Mohanty (INDIA) DISCUSSANT: 15:40 Syphilis and leprosy coinfection: a challenging Against - TBD diagnosis For - Phyllis Spuls (NETHERLANDS) A. Maralur Devegowda (INDIA)

15:50 Neglected Tropical Diseases (NTD) or Neglected People Diseases (NPD)? A. Morrone (ITALY) THURSDAY 13 JUNE, 2019

16:00 Australian Aboriginal and Torres Strait Islander 15:50 High levels of ige against tissue factor and dermatology thyroglobulin are reduced by omalizumab in D. F. Sebaratnam (AUSTRALIA) chronic spontaneous urticaria G. Genovese (ITALY) 16:10 Ultrasonography in Hansen’s disease S. Srinivasan (INDIA) 16:00 Evaluation of a low-dose methotrexate added to H1-antihistamines regimen for severe chronic 16:20 Epidemiological and clinical profile Dermatosis spontaneous urticaria: a phase III, randomized, at the malian refugees of Goudebou in Burkina placebo-controlled trial Faso S. Leducq (FRANCE) K. Yamoussa (MALI) 16:10 Effect of Omalizumab Treatment on Disease Activity in Chronic Spontaneous/Idiopathic WHITE 2 14:30-16:30 Urticaria: Results from XTEND-CIU, a Longitudinal Perspective Urticaria and pruritus M. Maurer (UNITED STATES) FC CO-CHAIRS: Monica Corazza (ITALY), 16:20 More Patients Treated with Ligelizumab are Roberta Fachini Jardim Criado (BRAZIL) Angioedema-free compared with Omalizumab: 14:30 Skin lesions, skin care and characteristics of Results of a Phase II Clinical Trial pruritus in patients with uremia undergoing M. Wallace (IRELAND) hemodialysis M. Augustin (GERMANY) YELLOW 1 14:30-16:30 14:40 Autoimmune thyroiditis and stress impairs treatment responses to omalizumab in chronic Autoimmune dermatoses and adverse drug urticaria and patients with angioedema and FC reactions higher body-mass-index may require longer CO-CHAIRS: Fabrizio Guarnieri (ITALY), treatment Mariano Suppa (BELGIUM) P. K. Can (TURKEY) 14:30 Female patients with dermatitis herpetiformis 14:50 Pathophysiology of Itch in Atopic Dermatitis: A showed a reduced diagnostic delay and have 3-Dimensional Study of IL-31 and its Receptors higher sensitivity rates at autoantibody testing and Cutaneous Innervation for celiac disease: a multi-centric Italian study T. Cao (SINGAPORE) E. Antiga (ITALY) 15:00 Subscutaneous auto serum therapy in chronic 14:40 Combination of tetracycline with nicotynamide spontaneous urticaria and clobetasol versus prednisone in bullous K. V. Godse (INDIA) pemphigoid: a retrospective analysis of 106 15:10 Subcutaneous Autologous Serum Therapy vs. patients with long-term follow-up Conventional Intramuscular Autologous Serum K. Woźniak (POLAND) Therapy in Chronic Urticaria: A Randomised, 14:50 Developing classification criteria for cutaneous Controlled Trial Comparing the Effectiveness dermatomyositis and Safety J. S. Concha (UNITED STATES) A. Datta (INDIA) 15:00 Alopecia in Autoimmune Blistering Diseases: A 15:20 Treatment of prurigo nodularis with serlopitant: Systematic Review of Pathogenesis and Clinical impact on itch and pain Features of Disease T. Domico (UNITED STATES) D. Xie (AUSTRALIA) 15:30 Activity during sleep measured by a sheet 15:10 Bullous disorders associated with anti-PD-1 and shaped body vibrometer is correlated with anti-PD-L1 therapy: A retrospective analysis severity of atopic dermatitis in adults: A evaluating the clinical and histopathologic comparison with wrist actigraphy measurement features, frequency, and impact on cancer T. Ebata (JAPAN) therapy. 15:40 Interleukin-31 couples itch sensation to J. Leventhal (UNITED STATES) inflammation in allergic skin disease M. Fassett (UNITED STATES) THURSDAY 13 JUNE, 2019

15:20 Prospective HLA-B*13:01 screening to prevent 15:20 Follicular Mycosis Fungoides presenting with dapsone hypersensitivity syndrome Spiky/Keratosis pilaris-like Lesions: An Indolent H. Liu (CHINA) Clinicopathologic Variant of Follicular Mycosis Fungoides 15:30 Implications of co-occurring dermatologic and C. F. Tomasini (ITALY) gastrointestinal toxicity from immune checkpoint inhibition therapy 15:30 Proposal for a staging classification of G.E. Molina (UNITED STATES) histopathological findings in Granulomaatous Cheilitis 15:40 Validating the BIOCHIP and interrater reliability B. Nikam (INDIA) in bullous pemphigoid and pemphigus patients A. Yang (AUSTRALIA) 15:40 SIRT3-dependent mitochondrial dynamic remodeling contributes to oxidative stress 15:50 Cutaneous side effects in the settings of induced melanocyte degeneration in vitiligo hematologic patients treated with Ibrutinib X. Yi (CHINA) A. Pileri (ITALY) 15:50 Poikilodermatous plaque-like hemangioma: a 16:00 Do oro-pharyngeal symptoms correlate with newly defined entity endoscopic findings in patients with pemphigus K. Semkova (UNITED KINGDOM) vulgaris? M. Bohdanowicz (UNITED STATES) 16:00 Cutaneous Rosai-Dorfman Disease: a report of eleven cases from China and a review of the 16:10 Clinical response to JAK inhibition in patients literature with familial chilblain lupus and TREX1 mutation G. Songmei (CHINA) C. Günter (GERMANY) 16:10 Genital basal cell carcinoma, a different 16:20 Major Psychological Complications and pathogenesis from sun-exposed basal cell Decreased Health-Related Quality of Life among carcinoma? A case-control study of 30 cases Survivors of Stevens-Johnson Syndrome and Y. J. Wang (CHINESE TAIPEI) Toxic Epidermal Necrolysis C. Olteanu (CANADA) 16:20 A retrospective analysis of histopathological features of morphea K. D. Rambhia (INDIA) YELLOW 2 14:30-16:30

Dermatopathology YELLOW 3 14:30-16:30 FC CO-CHAIRS: Carlo Francesco Tomasini (ITALY), Maria Eugenia Mazzei (URUGUAY) Paediatric dermatology, genetics and FC genodermatoses 14:30 Sub Corneal Pustular Dermatoses - A CO-CHAIRS: Anna Belloni Fortina (ITALY), clinicopathological study of 15 patients Jean Kanitakis (FRANCE) V. Gopalakrishnan (INDIA) 14:30 Evidence of common and differential genetic 14:40 Hand foot mouth disease in adults: the biomarkers for Ps and PsA importance of clinicopathological correlation R. Cascella (ITALY) and differential diagnosis J. Kim (AUSTRALIA) 14:40 Iatrogenic skin disorders and related factors in newborn infants 14:50 The contribution of Dermato(patho)logy in the Z. Csoma (HUNGARY) follow-up of Vascularized Composite Tissue Allografts (Hands, Face) 14:50 International survey on neonate hygiene and J. Kanitakis (FRANCE) skin care in Neonatal Intensive Care Units (NICUs) C. de Belilovsky (FRANCE) 15:00 Cutaneous lymphangitis carcinomatosa of breast cancer: about 5 cases 15:00 Insight into Lichen Planus: A retrospective F. Kettani (MOROCCO) analytical study of clinical, histopathological proﬁle and treatment response of 1872 patients 15:10 White lesions in oral cavity: a clinico over 22 years from North India – A Single Centre histopathological insight Experience S. Jaiswal (INDIA) D. Daulatabad Garg (INDIA) THURSDAY 13 JUNE, 2019

15:10 Skin manifestations in paediatric patients 15:50 Hair cross sectioning in uncombable hair treated with TNF-Alpha inhibitor for syndrome: an easy tool for a complex diagnosis inflammatory bowel disease: a retrospective V. Piccolo (ITALY) study 16:00 Irradiated Human Amniotic membrane Allograft A. Genois (CANADA) in patients with Dystrophic Epidermolysis 15:20 Novel Surgical Approach for Management of Bullosa Cutaneous Neurofibroma in Neurofibromatosis N. Radwan (EGYPT) Type 1 16:10 Localized scleroderma (MORPHEA) in children L. Le (UNITED STATES) and adolescents 15:30 A rare cause of recurrent leg ulcers, identified by J. Stojkovic-Filipovic (SERBIA) a novel mutation in PEPD gene: prolidase 16:20 Alopecia in Epidermolysis Bullosa: A Systematic deficiency Review of Pathogenesis and Clinical Features of E. Kiratli Nalbant (TURKEY) Disease 15:40 Kindler's syndrome, a clinical, genetic and D. Xie (AUSTRALIA) laboratory study of 210 cases in Panama, 1986 2017 H. Penagos (PANAMA)